Early Radiation Oncology Involvement Alongside Standard Oncologic Care for Radiation Therapy
Phase-Based Progress Estimates
Effectiveness
Safety
RWJBarnabas Health - Community Medical Center, Toms River, NJ
Radiation Therapy+2 More
Early Radiation Oncology Involvement Alongside Standard Oncologic Care - CombinationProductEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
To determine if the experimental approach of early radiation oncology involvement alongside standard oncologic care will result in higher HRQL at 6 months compared to the control arm receiving standard oncologic care alone, based on the global subscale score of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire.
Eligible Conditions
- Radiation Therapy
- Metastatic Cancers
Treatment Effectiveness
Effectiveness Progress
This is further along than 85% of similar trials
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 12 months
12 Months
Levels of HRQL
12 months
EORTC Core Quality of Life questionnaire (EORTC QLQ-C30)
Health Index Score
Vertical Visual Analogue Scale (EQ visual analogue scale)
At Six Months
Measure of Health-related quality of life (HRQL) at six months
Trial Safety
Safety Progress
This is further along than 85% of similar trials
Trial Design
2 Treatment Groups
Arm 1
1 of 2
Arm 2
1 of 2
Experimental Treatment
156 Total Participants · 2 Treatment Groups
Primary Treatment: Early Radiation Oncology Involvement Alongside Standard Oncologic Care · No Placebo Group · Phase 3
Arm 1
Other
Experimental Group · 1 Intervention: Questionnaires · Intervention Types: OtherArm 2
CombinationProduct
Experimental Group · 1 Intervention: Early Radiation Oncology Involvement Alongside Standard Oncologic Care · Intervention Types: CombinationProductTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months
Closest Location: RWJBarnabas Health - Community Medical Center · Toms River, NJ
N/AFirst Recorded Clinical Trial
1 TrialsResearching Radiation Therapy
0 CompletedClinical Trials
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
361 Previous Clinical Trials
60,031 Total Patients Enrolled
1 Trials studying Radiation Therapy
30 Patients Enrolled for Radiation Therapy
Malcolm Mattes, MDPrincipal InvestigatorRutgers Cancer Institute of New Jersey
2 Previous Clinical Trials
4 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have cancer, with primary site outside of the central nervous system.
You have metastatic disease for which curative intent treatment is not feasible and treatment goals are palliative.
You are able to understand the information you are being asked to provide and you are willing to sign a written informed consent document.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments